Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

The von Willebrand factor–binding aptamer rondaptivon pegol as a treatment for severe and nonsevere hemophilia A

Cihan Ay, Katarina D. Kovacevic, Daniel Kraemmer, Christian Schoergenhofer, Georg Gelbenegger, Christa Firbas, Peter Quehenberger, Petra Jilma-Stohlawetz, James C. Gilbert, Shuhao Zhu, Martin Beliveau, Franz Koenig, Alfonso Iorio, Bernd Jilma, Ulla Derhaschnig, Ingrid Pabinger

Blood (2023) 141 (10): 1147–1158.

https://doi.org/10.1182/blood.2022016571

Published: 2023

Includes: Supplemental data

Journal Articles

Emicizumab for the treatment of acquired hemophilia A

Paul Knoebl, Johannes Thaler, Petra Jilma, Peter Quehenberger, Karoline Gleixner, Wolfgang R. Sperr

Blood (2021) 137 (3): 410–419.

https://doi.org/10.1182/blood.2020006315

Published: 2021

Includes: Supplemental data

Journal Articles

Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: a first-in-human trial

Ulrich Jäger, Shirley D’Sa, Christian Schörgenhofer, Johann Bartko, Ulla Derhaschnig, Christian Sillaber, Petra Jilma-Stohlawetz, Michael Fillitz, Thomas Schenk, Gary Patou, Sandip Panicker, Graham C. Parry, James C. Gilbert, Bernd Jilma

Blood (2019) 133 (9): 893–901.

https://doi.org/10.1182/blood-2018-06-856930

Published: 2019

Includes: Supplemental data

Journal Articles

Emicizumab for the Treatment of Acquired Hemophilia_A: Lessons Learned from 4 Very Different Cases

Paul Knoebl, MD, Wolfgang R. Sperr, Peter Schellongowski, MD, Thomas Staudinger, MD, Petra Jilma-Stohlawetz, MD, Peter Quehenberger, MD, Silvia Koder, Ing, Cihan Ay, MD, Karoline V. Gleixner, MD

Blood (2018) 132 (Supplement 1): 2476.

https://doi.org/10.1182/blood-2018-99-116973

Published: 2018

Journal Articles

Long Term Efficacy, Safety and PK/PD Profile of the Anti-C1s Antibody (BIVV009) in Primary Cold Agglutinin Disease Patients

Ulrich Jaeger, MD, Shirley D'Sa, MD FRCP, FRCPath, Christian Schoergenhofer, MD, Johann Bartko, MD, Christian Sillaber, MD, Petra Jilma-Stohlawetz, MD, Michael Fillitz, MD, Thomas Schenk, MD, Gary Patou, MD, Sandip Panicker, PhD, Graham C Parry, PhD, James C Gilbert, MD, Bernd Jilma, MD

Blood (2017) 130 (Supplement 1): 703.

https://doi.org/10.1182/blood.V130.Suppl_1.703.703

Published: 2017

Journal Articles

Reversal Strategy For Antagonizing The P2Y12-Inhibitor Ticagrelor By Platelet Concentrates

Hobl Eva-Luise, PhD, Petra Jilma-Stohlawetz, MD, Ulla Derhaschnig, MD, Schoergenhofer Christian, MD, Michael Schwameis, MD, Bernd Jilma, MD

Blood (2013) 122 (21): 1153.

https://doi.org/10.1182/blood.V122.21.1153.1153

Published: 2013

Journal Articles

Acquired Von Willebrand Factor Deficiency Caused By Left Ventricular Assist Devices Is Adamts-13 Dependent

Petra Jilma-Stohlawetz, MD, Schima Heinrich, PhD, Martin Stoiber, Peter Quehenberger, MD, Sabine Schranz, RN, Bernd Jilma, MD

Blood (2013) 122 (21): 3602.

https://doi.org/10.1182/blood.V122.21.3602.3602

Published: 2013

Journal Articles

Inhibition of Von Willebrand Factor (VWF) by ARC1779 Normalizes Von Willebrand Factor/FVIII Levels and Corrects Thrombocytopenia in VWD Type 2b Patients,

Petra Jilma-Stohlawetz, MD, Paul Knoebl, MD, Ingrid Pabinger, MD, James Gilbert, MD, Robert G. Schaub, PhD, Bernd Jilma, MD

Blood (2011) 118 (21): 3377.

https://doi.org/10.1182/blood.V118.21.3377.3377

Published: 2011

Journal Articles

Effects of Strong P2Y12 Receptor Inhibition by Prasugrel on Platelet Inhibition During Endotoxemia: A Randomized Controlled Trial

Alexander O Spiel, MD, Ulla Derhaschnig, MD, Petra Jilma-Stohlawetz, MD, Bernd Jilma, MD

Blood (2011) 118 (21): 1245.

https://doi.org/10.1182/blood.V118.21.1245.1245

Published: 2011

Journal Articles

Proof of Concept for the Anti Von Willebrand Factor Aptamer in Patients with Relapsing Thrombotic Thrombocytopenic Purpura (TTP).

Bernd Ji lma, MD, Petra Jilma, MD, Petra Paulinska, MD, James C. Gilbert, MD, Renta Hutabarat, PhD, Trish Wagner, Paul Knoebl, MD

Blood (2008) 112 (11): 2290.

https://doi.org/10.1182/blood.V112.11.2290.2290

Published: 2008

Journal Articles

Functional Role of the Chemokine Binding Duffy Antigen Receptor Complex (DARC) in Human Inflammation In Vivo.

Florian B. Mayr, MD, Petra Jilma-Stohlawetz, MD, Christa Firbas, MD, Anthony F. Suffredini, MD, Hartmut Derendorf, MD, Bernd Jilma, MD

Blood (2006) 108 (11): 20.

https://doi.org/10.1182/blood.V108.11.20.20

Published: 2006

Journal Articles

The single nucleotide polymorphism Ser128Arg in the E-selectin gene is associated with enhanced coagulation during human endotoxemia

Bernd Jilma, Claudia Marsik, Florian Kovar, Oswald F. Wagner, Petra Jilma-Stohlawetz, Georg Endler

Blood (2005) 105 (6): 2380–2383.

https://doi.org/10.1182/blood-2004-09-3752

Published: 2005

Journal Articles

Desmopressin antagonizes the in vitro platelet dysfunction induced by GPIIb/IIIa inhibitors and aspirin

Rosemarie A. Reiter, Florian Mayr, Hannes Blazicek, Elisabeth Galehr, Petra Jilma-Stohlawetz, Hans Domanovits, Bernd Jilma

Blood (2003) 102 (13): 4594–4599.

https://doi.org/10.1182/blood-2002-11-3566

Published: 2003

Journal Articles

Effects of erythropoietin on platelet reactivity and thrombopoiesis in humans

Petra Jilma Stohlawetz, Larisa Dzirlo, Nicole Hergovich, Edith Lackner, Christa Mensik, Hans Georg Eichler, Eva Kabrna, Klaus Geissler, Bernd Jilma

Blood (2000) 95 (9): 2983–2989.

https://doi.org/10.1182/blood.V95.9.2983.009k27_2983_2989

Published: 2000

NARROW

The von Willebrand factor–binding aptamer rondaptivon pegol as a treatment for severe and nonsevere hemophilia A

Emicizumab for the treatment of acquired hemophilia A

Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: a first-in-human trial

Emicizumab for the Treatment of Acquired Hemophilia_A: Lessons Learned from 4 Very Different Cases

Long Term Efficacy, Safety and PK/PD Profile of the Anti-C1s Antibody (BIVV009) in Primary Cold Agglutinin Disease Patients

Reversal Strategy For Antagonizing The P2Y12-Inhibitor Ticagrelor By Platelet Concentrates

Acquired Von Willebrand Factor Deficiency Caused By Left Ventricular Assist Devices Is Adamts-13 Dependent

Inhibition of Von Willebrand Factor (VWF) by ARC1779 Normalizes Von Willebrand Factor/FVIII Levels and Corrects Thrombocytopenia in VWD Type 2b Patients,

Effects of Strong P2Y12 Receptor Inhibition by Prasugrel on Platelet Inhibition During Endotoxemia: A Randomized Controlled Trial

Proof of Concept for the Anti Von Willebrand Factor Aptamer in Patients with Relapsing Thrombotic Thrombocytopenic Purpura (TTP).

Functional Role of the Chemokine Binding Duffy Antigen Receptor Complex (DARC) in Human Inflammation In Vivo.

The single nucleotide polymorphism Ser128Arg in the E-selectin gene is associated with enhanced coagulation during human endotoxemia

Desmopressin antagonizes the in vitro platelet dysfunction induced by GPIIb/IIIa inhibitors and aspirin

Effects of erythropoietin on platelet reactivity and thrombopoiesis in humans

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only